Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 410
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT00066573 | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer | ||
| NCT00003653 | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | ||
| NCT00390169 | Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients | ||
| NCT01479283 | Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) | ||
| NCT00741364 | Vitamin D Effects on Prostate Pathology | ||
| NCT01068587 | MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy | ||
| NCT02337530 | Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC | ||
| NCT03461952 | Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe) | ||
| NCT03385655 | Prostate Cancer Biomarker Enrichment and Treatment Selection | ||
| NCT04557501 | PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer | ||
| NCT00820248 | Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer | ||
| NCT01972984 | Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients | ||
| NCT02537418 | Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens | ||
| NCT01486368 | A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma | ||
| NCT00005974 | Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma | ||
| NCT00535353 | AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | ||
| NCT03585634 | The Dads in Gear Program: An Innovative Men-centered Approach to Smoking Cessation | ||
| NCT00372736 | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | ||
| NCT00260975 | Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer | ||
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | ||
| NCT00016380 | Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | ||
| NCT00371553 | Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer | ||
| NCT00352079 | BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer | ||
| NCT02065960 | Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer | ||
| NCT00343408 | AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer | ||
| NCT05264740 | Motivational Interviewing to Promote Healthy Behaviours in Young Adults | ||
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) | ||
| NCT01805778 | Preventing Cardiac Sequelae in Pediatric Cancer Survivors | ||
| NCT03944798 | Surveillance AFter Extremity Tumor surgerY | ||
| NCT01591421 | P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. | ||
| NCT00514085 | Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma | ||
| NCT00238316 | Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density | ||
| NCT05470010 | Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors | ||
| NCT02058615 | Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer | ||
| NCT03548636 | Project MOVE: Increasing Physical Activity Among Breast Cancer Survivors | ||
| NCT06863129 | Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial | ||
| NCT00443976 | Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma | ||
| NCT00377052 | Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma | ||
| NCT00028743 | Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT05116137 | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors | ||
| NCT01089764 | Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer | ||
| NCT01968941 | Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients | ||
| NCT01783197 | Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC | ||
| NCT02960087 | Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer | ||
| NCT00053794 | Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | ||
| NCT03477591 | Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | ||
| NCT06915779 | Long Term Follow-up of HPV Vaccine in HIV (CTN 236) | ||
| NCT00083174 | Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer | ||
| NCT00040183 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. |
